Home › Companies › ROIVANT SCIENCES LTD. › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and ROIVANT SCIENCES LTD.’s Form 8-K, filed September 16, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of September 10, 2024: 5 items on ROIVANT SCIENCES LTD.’s Form 8-K, filed September 16, 2024: 3 elected · 2 approved.
Significant dissent: 2 directors (32.3%, 24.4% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2023-2024 2024-2025 2025-2026
Activist investors: Rubric Capital (13F, 1.0%, as of September 30, 2026) · Two Seas Capital LP (13F, 1.0%, as of September 30, 2026)
Explore ROIVANT SCIENCES LTD. in the interactive database Compare manager voting policies
These tallies are ROIVANT SCIENCES LTD.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed September 16, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Ilan Oren | 409,647,664 | -- | -- | 195,587,109 | 74,881,529 | 68% | Elected | — |
| Elect Director: James C. Momtazee | 457,800,746 | -- | -- | 147,434,027 | 74,881,529 | 76% | Elected | — |
| Elect Director: Dr. Mayukh Sukhatme | 602,544,381 | -- | -- | 2,690,392 | 74,881,529 | 99.6% | Elected | — |
| 2. The appointment of Ernst & Young LLP ("EY") to serve as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2025, and to appoint EY as the Company's auditor for statutory purposes under the Bermuda Com | 679,096,310 | 759,669 | 260,323 | -- | -- | 99.9% | Approved | a majority of the votes cast |
| 3. On a non-binding advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement, including the compensation tables and related narrative disclosures | 540,184,951 | 64,461,892 | 587,930 | -- | 74,881,529 | 89% | Approved | — |
Source: ROIVANT SCIENCES LTD., Form 8-K, filed with the SEC on September 16, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2024-2025: shareholder support by sector and by company size.
261 asset managers disclosed a vote on at least one ROIVANT SCIENCES LTD. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of ROIVANT SCIENCES LTD.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 7 wordings of this item as funds reported it.
68% Majority: yes · of votes cast
Description as filed by funds: To elect the Board of Directors' three nominees for Class III Director to serve for a three-year term: Ilan Oren
ROIVANT SCIENCES LTD.’s own tally for this item (“Elect Director: Ilan Oren”): 409,647,664 for, 195,587,109 withheld, per its Form 8-K filed September 16, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(1) Shareholders re-elected the individuals named below to serve as Class III directors of the Company, to hold office until the date of the annual general meeting of shareholders following the fiscal year ending March 31, 2027, and until their successors are duly elected and qualified, or until su…”
Support: 68% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 73 asset managers below reported 33,541,414 for, 49,038,153 withheld, 19,247,111 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 5,331,113 | 0 | 0 | 26,091,057 | Mixed |
| BlackRock | 0 | 0 | 18,354,542 | 0 | Abstain |
| Vanguard | 9,537,666 | 0 | 0 | 0 | For |
| Morgan Stanley | 8,318,539 | 0 | 0 | 23,833 | For |
| State Street | 0 | 0 | 0 | 4,894,717 | Withhold |
| Invesco | 0 | 0 | 0 | 4,623,241 | Withhold |
| TIAA | 3,189,883 | 0 | 0 | 0 | For |
| First Trust | 0 | 0 | 0 | 3,082,289 | Withhold |
| Goldman Sachs | 0 | 0 | 0 | 2,622,027 | Withhold |
| Charles Schwab | 2,122,291 | 0 | 0 | 0 | For |
| Transamerica | 1,842,461 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 0 | 0 | 0 | 1,600,000 | Withhold |
| Aberdeen | 0 | 0 | 0 | 1,126,987 | Withhold |
| Equitable | 276,289 | 0 | 0 | 631,346 | Mixed |
| Brighthouse | 765,910 | 0 | 0 | 123,960 | Mixed |
| Jackson National | 686,042 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 582,211 | Withhold |
| FRANKLIN STRATEGIC SERIES | 0 | 0 | 0 | 346,000 | Withhold |
| Delaware/Macquarie | 0 | 0 | 0 | 338,181 | Withhold |
| Columbia Threadneedle | 0 | 0 | 0 | 332,855 | Withhold |
| Mercer Funds | 0 | 0 | 0 | 326,459 | Withhold |
| MoA Funds Corp | 0 | 0 | 0 | 318,416 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 281,232 | Withhold |
| Northern Trust | 261,743 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 0 | 0 | 223,278 | 0 | Abstain |
Showing the 25 largest of 73 asset managers. All 73 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
76% Majority: yes · of votes cast
Description as filed by funds: To elect the Board of Directors' three nominees for Class III Director to serve for a three-year term: James C. Momtazee
ROIVANT SCIENCES LTD.’s own tally for this item (“Elect Director: James C. Momtazee”): 457,800,746 for, 147,434,027 withheld, per its Form 8-K filed September 16, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(1) Shareholders re-elected the individuals named below to serve as Class III directors of the Company, to hold office until the date of the annual general meeting of shareholders following the fiscal year ending March 31, 2027, and until their successors are duly elected and qualified, or until su…”
Support: 76% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 73 asset managers below reported 64,309,606 for, 36,886,728 withheld, 630,344 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 5,507,393 | 0 | 0 | 25,914,777 | Mixed |
| BlackRock | 18,354,542 | 0 | 0 | 0 | For |
| Vanguard | 9,537,666 | 0 | 0 | 0 | For |
| Morgan Stanley | 8,342,372 | 0 | 0 | 0 | For |
| State Street | 4,894,717 | 0 | 0 | 0 | For |
| Invesco | 4,623,241 | 0 | 0 | 0 | For |
| TIAA | 3,189,883 | 0 | 0 | 0 | For |
| First Trust | 0 | 0 | 0 | 3,082,289 | Withhold |
| Goldman Sachs | 0 | 0 | 0 | 2,622,027 | Withhold |
| Charles Schwab | 2,122,291 | 0 | 0 | 0 | For |
| Transamerica | 1,842,461 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 1,600,000 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 0 | 0 | 1,126,987 | Withhold |
| Equitable | 433,054 | 0 | 0 | 474,581 | Mixed |
| Brighthouse | 765,910 | 0 | 0 | 123,960 | Mixed |
| Jackson National | 686,042 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 582,211 | Withhold |
| FRANKLIN STRATEGIC SERIES | 0 | 0 | 0 | 346,000 | Withhold |
| Delaware/Macquarie | 0 | 0 | 0 | 338,181 | Withhold |
| Columbia Threadneedle | 332,855 | 0 | 0 | 0 | For |
| Mercer Funds | 0 | 0 | 0 | 326,459 | Withhold |
| MoA Funds Corp | 0 | 0 | 0 | 318,416 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 281,232 | Withhold |
| Northern Trust | 261,743 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 25,576 | 0 | 197,702 | 0 | Mixed |
Showing the 25 largest of 73 asset managers. All 73 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
Description as filed by funds: To elect the Board of Directors' three nominees for Class III Director to serve for a three-year term: Mayukh Sukhatme
ROIVANT SCIENCES LTD.’s own tally for this item (“Elect Director: Dr. Mayukh Sukhatme”): 602,544,381 for, 2,690,392 withheld, per its Form 8-K filed September 16, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(1) Shareholders re-elected the individuals named below to serve as Class III directors of the Company, to hold office until the date of the annual general meeting of shareholders following the fiscal year ending March 31, 2027, and until their successors are duly elected and qualified, or until su…”
Support: 99.6% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 73 asset managers below reported 100,868,553 for, 269,294 withheld, 688,831 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 31,422,170 | 0 | 0 | 0 | For |
| BlackRock | 18,354,542 | 0 | 0 | 0 | For |
| Vanguard | 9,537,666 | 0 | 0 | 0 | For |
| Morgan Stanley | 8,342,372 | 0 | 0 | 0 | For |
| State Street | 4,894,717 | 0 | 0 | 0 | For |
| Invesco | 4,623,241 | 0 | 0 | 0 | For |
| TIAA | 3,189,883 | 0 | 0 | 0 | For |
| First Trust | 3,082,289 | 0 | 0 | 0 | For |
| Goldman Sachs | 2,622,027 | 0 | 0 | 0 | For |
| Charles Schwab | 2,122,291 | 0 | 0 | 0 | For |
| Transamerica | 1,842,461 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 1,600,000 | 0 | 0 | 0 | For |
| Aberdeen | 1,126,987 | 0 | 0 | 0 | For |
| Equitable | 907,635 | 0 | 0 | 0 | For |
| Brighthouse | 889,870 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 686,042 | 0 | Abstain |
| Direxion Shares ETF Trust | 582,211 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 346,000 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 338,181 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 332,855 | 0 | 0 | 0 | For |
| Mercer Funds | 326,459 | 0 | 0 | 0 | For |
| MoA Funds Corp | 318,416 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 281,232 | 0 | 0 | 0 | For |
| Northern Trust | 261,743 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 223,278 | 0 | 0 | 0 | For |
Showing the 25 largest of 73 asset managers. All 73 are in the interactive database (link above).
Combines 10 wordings of this item as funds reported it.
89% Approved · of votes cast
Description as filed by funds: To cast a non-binding, advisory vote to approve the compensation of our named executive officers.
ROIVANT SCIENCES LTD.’s own tally for this item (“3. On a non-binding advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement, including the compensation tables and related narrative disclosures”): 540,184,951 for, 64,461,892 against — passed, per its Form 8-K filed September 16, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “(3) Shareholders approved, on a non-binding advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement, including the compensation tables and related narrative disclosures.”
Support: 89% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of ROIVANT SCIENCES LTD.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Say on pay” (2 managers, 276,530 for).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 5,507,393 | 25,914,777 | 0 | 0 | Mixed |
| BlackRock | 18,354,542 | 0 | 0 | 0 | For |
| Vanguard | 9,537,666 | 0 | 0 | 0 | For |
| Morgan Stanley | 8,342,372 | 0 | 0 | 0 | For |
| State Street | 4,894,717 | 0 | 0 | 0 | For |
| Invesco | 4,623,241 | 0 | 0 | 0 | For |
| TIAA | 3,189,883 | 0 | 0 | 0 | For |
| First Trust | 3,082,289 | 0 | 0 | 0 | For |
| Goldman Sachs | 2,622,027 | 0 | 0 | 0 | For |
| Charles Schwab | 2,122,291 | 0 | 0 | 0 | For |
| Transamerica | 1,842,461 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 0 | 1,600,000 | 0 | 0 | Against |
| Aberdeen | 1,126,987 | 0 | 0 | 0 | For |
| Equitable | 517,921 | 389,714 | 0 | 0 | Mixed |
| Brighthouse | 889,870 | 0 | 0 | 0 | For |
| Jackson National | 686,042 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 582,211 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 346,000 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 338,181 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 332,855 | 0 | 0 | 0 | For |
| Mercer Funds | 0 | 326,459 | 0 | 0 | Against |
| MoA Funds Corp | 318,416 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 281,232 | 0 | 0 | 0 | For |
| Northern Trust | 261,743 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 223,278 | 0 | 0 | 0 | For |
Fund voting reports, all 72 managers: 72,581,077 for, 29,170,785 against, 74,815 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 68,482,995 | 0 | 0 | 0 | For |
| VIKING GLOBAL INVESTORS LP | 66,924,269 | 0 | 0 | 0 | For |
| QVT Financial LP | 66,719,779 | 0 | 0 | 0 | For |
| Fidelity | 0 | 46,381,587 | 0 | 0 | Against |
| Morgan Stanley | 24,295,310 | 0 | 0 | 0 | For |
| BlackRock | 13,152,685 | 33,867 | 0 | 0 | For |
| State Street | 10,390,877 | 814 | 0 | 0 | For |
| Woodline Partners LP | 7,037,324 | 0 | 0 | 0 | For |
| Rubric Capital Management LP | 6,782,179 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 5,942,231 | 0 | 0 | 0 | For |
| Two Seas Capital LP | 5,710,472 | 0 | 0 | 0 | For |
| Invesco | 4,882,620 | 0 | 0 | 0 | For |
| Capital Group | 4,832,642 | 0 | 0 | 0 | For |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,669,200 | 0 | 0 | 0 | For |
| Nuveen | 3,211,988 | 0 | 0 | 0 | For |
| Pertento Partners LLP | 2,652,562 | 0 | 0 | 0 | For |
| Loomis Sayles | 130,250 | 2,520,275 | 0 | 0 | Against |
| DME Capital Management, LP | 2,505,546 | 0 | 0 | 0 | For |
| Whitefort Capital Management, LP | 2,391,000 | 0 | 0 | 0 | For |
| Northern Trust | 2,154,183 | 362 | 0 | 0 | For |
| Charles Schwab | 2,126,700 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 1,954,419 | 0 | 0 | 0 | For |
| TOMS Capital Investment Management LP | 1,920,651 | 0 | 0 | 0 | For |
| Clearbridge Investments, LLC | 1,860,536 | 0 | 0 | 0 | For |
| Citadel | 1,765,130 | 0 | 0 | 0 | For |
Institutional-manager reports, all 209 managers: 331,061,220 for, 56,644,283 against, 735,828 abstained, 240 not voted, 481,375 1 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 10 wordings of this item as funds reported it.
99.7% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: To cast a non-binding, advisory vote on the frequency of future non-binding, advisory votes to approve the compensation of our named executive officers every:
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| Morgan Stanley | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| TIAA | 0 | 0 | 0 | 0 | -- |
| First Trust | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Transamerica | 0 | 0 | 0 | 0 | -- |
| IMPAX FUNDS SERIES TRUST I | 0 | 0 | 0 | 0 | -- |
| Aberdeen | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| Brighthouse | 0 | 0 | 0 | 0 | -- |
| Jackson National | 0 | 0 | 0 | 0 | -- |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 0 | -- |
| FRANKLIN STRATEGIC SERIES | 0 | 0 | 0 | 0 | -- |
| Delaware/Macquarie | 0 | 0 | 0 | 0 | -- |
| Columbia Threadneedle | 0 | 0 | 0 | 0 | -- |
| Mercer Funds | 0 | 0 | 0 | 0 | -- |
| MoA Funds Corp | 0 | 0 | 0 | 0 | -- |
| AIG/SunAmerica | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Bridge Builder Trust | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 69 managers: 32,386 for, 74,815 abstained, 101,172,411 1 year, 198,600 3 year, 105,000 unknown. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | 0 | 0 | 0 | 0 | -- |
| QVT Financial LP | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| Morgan Stanley | 0 | 0 | 0 | 0 | -- |
| BlackRock | 2,710,836 | 0 | 0 | 0 | For |
| State Street | 0 | 0 | 0 | 0 | -- |
| Woodline Partners LP | 0 | 0 | 0 | 0 | -- |
| Rubric Capital Management LP | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Two Seas Capital LP | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| Capital Group | 0 | 0 | 0 | 0 | -- |
| Nuveen | 0 | 0 | 0 | 0 | -- |
| Pertento Partners LLP | 0 | 0 | 0 | 0 | -- |
| Loomis Sayles | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | Not Voted |
| MELLON INVESTMENTS Corp | 0 | 0 | 0 | 0 | -- |
| TOMS Capital Investment Management LP | 0 | 0 | 0 | 0 | -- |
| Clearbridge Investments, LLC | 0 | 0 | 0 | 0 | -- |
| Citadel | 0 | 0 | 0 | 0 | -- |
| LAKEWOOD CAPITAL MANAGEMENT, LP | 0 | 0 | 0 | 0 | -- |
| IMPAX ASSET MANAGEMENT LLC | 0 | 0 | 0 | 0 | -- |
| RTW INVESTMENTS, LP | 0 | 0 | 0 | 0 | -- |
| Point72 | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 197 managers: 3,191,305 for, 9,900 against, 734,263 abstained, 240 not voted, 297,018,410 1 year, 5,710,472 unknown, 2,128,881 3 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Prior year: 100.0% for (September 12, 2023 meeting) ▼ 0.1 pts
Description as filed by funds: To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as Roivant's independent registered public accounting firm for Roivant's fiscal year ending March 31, 2025, to appoint Ernst & Young LLP as auditor for statutory purposes under the Bermuda Companies Act 1981, as amended, for Roivant's fiscal year ending March 31, 2025, and to authorize the Board of Directors, through the Audit Committee, to set the remuneration for Ernst & Young LLP as Roivant's auditor for Roivant's fiscal year ending March 31, 2025.
ROIVANT SCIENCES LTD.’s own tally for this item (“2. The appointment of Ernst & Young LLP ("EY") to serve as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2025, and to appoint EY as the Company's auditor for statutory p”): 679,096,310 for, 759,669 against — passed, per its Form 8-K filed September 16, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “(2) Shareholders ratified the appointment of Ernst & Young LLP ("EY") to serve as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2025, and to appoint EY as the Company's auditor for statutory purposes under the Bermuda Companies Act 1981, as amended…”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Voting standard, as the filing states it: a majority of the votes cast (“majority of the votes cast”).
The 74 asset managers below reported 101,756,505 for, 74,815 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 31,422,170 | 0 | 0 | 0 | For |
| BlackRock | 18,354,542 | 0 | 0 | 0 | For |
| Vanguard | 9,537,666 | 0 | 0 | 0 | For |
| Morgan Stanley | 8,342,372 | 0 | 0 | 0 | For |
| State Street | 4,894,717 | 0 | 0 | 0 | For |
| Invesco | 4,623,241 | 0 | 0 | 0 | For |
| TIAA | 3,189,883 | 0 | 0 | 0 | For |
| First Trust | 3,082,289 | 0 | 0 | 0 | For |
| Goldman Sachs | 2,622,027 | 0 | 0 | 0 | For |
| Charles Schwab | 2,122,291 | 0 | 0 | 0 | For |
| Transamerica | 1,842,461 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 1,600,000 | 0 | 0 | 0 | For |
| Aberdeen | 1,126,987 | 0 | 0 | 0 | For |
| Equitable | 907,635 | 0 | 0 | 0 | For |
| Brighthouse | 889,870 | 0 | 0 | 0 | For |
| Jackson National | 686,042 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 582,211 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 346,000 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 338,181 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 332,855 | 0 | 0 | 0 | For |
| Mercer Funds | 326,459 | 0 | 0 | 0 | For |
| MoA Funds Corp | 318,416 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 281,232 | 0 | 0 | 0 | For |
| Northern Trust | 261,743 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 223,278 | 0 | 0 | 0 | For |
Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 739,053,106 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 4.25% |
| 2 | BlackRock | 2.48% |
| 3 | Vanguard | 1.29% |
| 4 | Morgan Stanley | 1.13% |
| 5 | State Street | 0.66% |
| 6 | Invesco | 0.63% |
| 7 | TIAA | 0.43% |
| 8 | First Trust | 0.42% |
| 9 | Goldman Sachs | 0.35% |
| 10 | Charles Schwab | 0.29% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | SB INVESTMENT ADVISERS (UK) LTD | 9.27% |
| 2 | VIKING GLOBAL INVESTORS LP | 9.06% |
| 3 | QVT Financial LP | 9.03% |
| 4 | Fidelity | 6.28% |
| 5 | Morgan Stanley | 3.29% |
| 6 | BlackRock | 1.78% |
| 7 | State Street | 1.41% |
| 8 | Woodline Partners LP | 0.95% |
| 9 | Rubric Capital Management LP | 0.92% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 0.80% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Roivant Sciences Ltd. | 113,327,007 | 15.33% | Schedule 13D, filed December 12, 2025 |
| Dexxon Holdings | 102,849,443 | 13.92% | Proxy statement (DEF 14A), proxy filed July 29, 2025 |
| Vivek Ramaswamy | 80,222,851 | 10.85% | Proxy statement (DEF 14A), proxy filed July 29, 2025 |
| SVF Investments | 62,057,537 | 8.40% | Proxy statement (DEF 14A), proxy filed July 29, 2025 |
| FMR (Fidelity) | 51,666,511 | 6.99% | Form 13F, quarter ended March 31, 2025 |
| FMR LLC | 49,145,056 | 6.65% | Proxy statement (DEF 14A), proxy filed July 29, 2025 |
| Viking Global Entities | 46,013,752 | 6.23% | Proxy statement (DEF 14A), proxy filed July 29, 2025 |
| BlackRock | 41,659,488 | 5.64% | Form 13F, quarter ended March 31, 2025 |
| Vanguard Group | 40,767,590 | 5.52% | Form 13F, quarter ended March 31, 2025 |
| Morgan Stanley | 35,926,759 | 4.86% | Form 13F, quarter ended March 31, 2025 |
Percentages above are of 739,053,106 shares outstanding, as reported by ROIVANT SCIENCES LTD. on its Form 10-Q dated June 30, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At ROIVANT SCIENCES LTD.'s shareholder meeting held September 10, 2024, in the 2024-2025 proxy season, 261 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 2,309 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To cast a non-binding, advisory vote to approve the compensation of our named executive… — ROIVANT SCIENCES LTD.'s filing reports the proposal as approved, with 89% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: ROIVANT SCIENCES LTD.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on September 16, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ROIVANT SCIENCES LTD.’s 10-Q dated June 30, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
ROIVANT SCIENCES LTD. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Proxy Votes Now, “ROIVANT SCIENCES (ROIV) 2024 Annual Meeting (2024-2025 season)”, https://proxyvotesnow.com/company/roivant-sciences-ltd/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.